Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-55f67697df-zh294 Total loading time: 0 Render date: 2025-05-11T12:37:24.975Z Has data issue: false hasContentIssue false

Cancer: leukaemia

from Medical topics

Published online by Cambridge University Press:  18 December 2014

By
Janelle L. Wagner  and
Ronald T. Brown
Edited by
Susan Ayers ,
Andrew Baum ,
Chris McManus ,
Stanton Newman ,
Kenneth Wallston ,
John Weinman  and
Robert West
Janelle L. Wagner
Affiliation:
Medical University of South Carolina
Ronald T. Brown
Affiliation:
Medical University of South Carolina
Susan Ayers
Affiliation:
University of Sussex
Andrew Baum
Affiliation:
University of Pittsburgh
Chris McManus
Affiliation:
St Mary's Hospital Medical School
Stanton Newman
Affiliation:
University College and Middlesex School of Medicine
Kenneth Wallston
Affiliation:
Vanderbilt University School of Nursing
John Weinman
Affiliation:
United Medical and Dental Schools of Guy's and St Thomas's
Robert West
Affiliation:
St George's Hospital Medical School, University of London
Get access

Summary

Overview

The leukaemias are a group of cancers of the blood forming tissues that are typically characterized by the type of white blood cells that is affected (lymphoid or myeloid) and the progressive nature of the abnormal cells (acute versus chronic). There are four common types of leukaemia: (i) acute lymphocytic leukaemia (ALL); (ii) chronic lymphocytic leukaemia (CLL); (iii) acute myeloid leukaemia (AML); and (iv) chronic myeloid leukaemia (CML). Specifically, ALL is defined as an abnormal white blood cell count and differential, abnormal haematocrit/haemoglobin and platelet counts, abnormal bone marrow with more than 5% blasts (immature cells), and signs and symptoms of the disease (http://cancer.gov). ALL and AML occur in both children and adults, although the chronic leukaemias (CLL, CML) affect primarily adults. Approximately 89% of leukaemia cases occur in adults over the age of 60 years (Lesko, 1998). The incidence of leukaemia in the United States is 10.9 per 100 000 individuals compared to 8.5 per 100 000 individuals in the United Kingdom (Parkin et al., 1997).

The specific aetiology of leukaemia is unknown, although risk factors may consist of prenatal exposure to radiation and postnatal exposure to various toxins (see ‘Toxins: environmental’). Treatments typically used in the management of specific neoplasms often place individuals at secondary risk for other malignancies including leukaemia. Down's syndrome and other genetic disorders, such as neurofibromatosis also pose significant risk factors for the development of leukaemia (NIH Publication number 02-3775 retrieved from http://cancer.gov).

Type
Chapter
Information
Cambridge Handbook of Psychology, Health and Medicine , pp. 601 - 605
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Aaronson, N. K. (1989). Quality of life assessment in clinical trials: methodological issues. Controlled Clinical Trials, 10(4), 195S–208S.CrossRefGoogle Scholar
Andrykowksi, M. A., Greinder, C. B., Altmaier, E. M.et al. (1995). Quality of life following bone marrow transplantation: findings from a multi-centre study. British Journal of Cancer, 7(6), 1322–9.CrossRefGoogle Scholar
Burish, T. G., Carey, M. P., Krozely, M. G. & Greco, F. A. (1987). Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. Journal of Consulting and Clinical Psychology, 55, 42–8.CrossRefGoogle Scholar
Burish, T. G., Snyder, S. L. & Jenkins, R. A. (1991). Preparing patients for cancer chemotherapy: effect of coping preparing and relaxation interventions. Journal of Consulting and Clinical Psychology, 59, 518–25.CrossRefGoogle Scholar
Carey, M. P. & Burish, T. G. (1987). Providing relaxation training to cancer chemotherapy patients: a comparison of three delivery techniques. Journal of Consulting and Clinical Psychology, 55, 732–7.CrossRefGoogle Scholar
Caudell, K. A. (1996). Psychoneuroimmunology and innovative behavioral interventions in patients with leukemia. Oncology Nursing Forum, 23(3), 493–502.Google Scholar
Leeuw, J. R., Graeff, A., Ros, W. J.et al. (2000). Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psycho-oncology, 9(1), 20–8.3.0.CO;2-Y>CrossRefGoogle Scholar
Dermatis, H. & Lesko, L. M. (1991). Psychosocial correlates of physician-patient communication at the time of informed consent for bone marrow transplantation. Cancer Investigation, 9(6), 621–8.CrossRefGoogle Scholar
Detmar, S. B., Aaronson, N. K., Wever, L. D., Muller, M. & Schornagel, J. H. (2000). How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality of life issues. Journal of Clinical Oncology, 18(18), 3295–301.Google Scholar
Greenberg, D. B., Kornblith, A. B., Herndon, J. E.et al. (1997). Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971–1988: predictors for later psychologic distress. Cancer, 80(10), 1936–44.3.0.CO;2-Z>CrossRefGoogle Scholar
Hoelzer, D., Gokbuget, N., Ottmann, O.et al. (2002). Acute lymphoblastic leukemia. American Society of Hematology, 162–92.CrossRefGoogle Scholar
Holland, J. C. (1998). Psycho-oncology. New York: Oxford University Press.
Holland, J. C. & Gooen-Piels, J. (2000). Principles of psycho-oncology. In Holland, J. C., Frei, E. & Decker, B. C. (Eds.). Cancer Medicine, (5th edn.). (pp. 943–58). Hamilton, Canada: BC Decker Inc.
Kazak, A. E. & Barakat, L. P. (1997). Brief report: parenting stress and quality of life during treatment for childhood leukemia predicts child and parent adjustment after treatment ends. Journal of Pediatric Psychology, 22(5), 749–58.CrossRefGoogle Scholar
Keating, M. J., McCredie, K. B., Bodey, G. P.et al. (1982). Improved prospects for long-term survival in adults with acute myelogenous leukemia. Journal of the American Medical Assocation, 248(19), 2481–6.CrossRefGoogle Scholar
Larson, D. B. & Milano, M. A. G. (1995). Are religion and spirituality clinically relevant in health care?Mind/Body Medicine, 1(3), 147–57.Google Scholar
Lesko, L. M. (1998). Hematopoietic dyscrasias. In Holland, J. C. (Ed.). Psycho-oncology (pp. 406–16). New York: Oxford University Press.
Lesko, L. M., Ostroff, J. S., Mumma, G. H., Mashberg, D. E. & Holland, J. C. (1992). Long term psychological adjustment of acute leukemia survivors: impact of bone marrow transplantation versus conventional chemotherapy. Psychosomatic Medicine, 54(1), 30–47.CrossRefGoogle Scholar
Montgomery, C., Pocock, M., Titley, K. & Lloyd, K. (2003). Predicting psychological distress in patients with leukemia and lymphoma. Journal of Psychosomatic Research, 54, 289–92.CrossRefGoogle Scholar
Mundy, E. A., DuHamel, K. N. & Montgomery, G. H. (2003). The efficacy of behavioral interventions for cancer treatment-related side effects. Seminars in Clinical Neuropsychiatry, 8(4), 253–75.Google Scholar
National Institute of Cancer. Adult acute lymphoblastic leukemia. Retrieved May 22, 2004, from http://cancer.org
National Institute of Cancer. (posted 3/31/2003). NIH Publication No. 02–3775. Retrieved May 22, 2004, from http://cancer.org
Noll, R. B., MacLean, W. E. Jr., Whitt, J. K.et al. (1997). Behavioral adjustment and social functioning of long-term survivors of childhood leukemia: parent and teacher reports. Journal of Pediatric Psychology, 22(6), 827–41.CrossRefGoogle Scholar
Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L. & Young, J. (Eds.). (1997). Cancer incidence in five continents, Vol. VII (IARC Scientific Publications No. 143). Lyon, France: IARC.
Patrick, D. L., Ferketich, S. L., Frame, P. S.et al. (2003). National Institutes of Health State of the Science Conference statement: symptoms management in cancer: pain, depression, and fatigue, July 15–17, 2002. Journal of the National Cancer Institute, 95(15), 1110–17.CrossRefGoogle Scholar
Pui, C. H. & Evans, W. E. (1998). Acute lymphoblastic leukemia. New England Journal of Medicine, 339, 605–15.CrossRefGoogle Scholar
Redaelli, A., Stephens, J. M., Brandt, S., Botteman, M. F. & Pashos, C. L. (2004). Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treatment Reviews, 30, 103–17.CrossRefGoogle Scholar
Schumacher, A., Wewers, D., Heinecke, A.et al. (2002). Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia. Leukemia Research, 26(4), 355–62.CrossRefGoogle Scholar
Spiegel, D. (1996). Cancer and depression. British Journal of Psychiatry, 168(30), 109–16.CrossRefGoogle Scholar
Spiegel, D. (1997). Psychosocial aspects of breast cancer treatment. Seminars in Oncology, 24(Suppl. 1), S1 36–S1 47.Google Scholar
Stark, D., Kiely, M., Smith, A.et al. (2002). Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. Journal of Clinical Oncology, 20(14), 3137–48.CrossRefGoogle Scholar
Stuber, M. L., Meeske, K., Gonzalez, S. (1994). Post-traumatic stress after childhood cancer: the role of appraisal. Psycho-oncology, 3, 305–12.CrossRefGoogle Scholar
Vannatta, K. & Gerhardt, C. A. (2003). Pediatric oncology. In Roberts, M. (Ed.). Handbook of Pediatric Psychology, (3rd edn.). (pp. 342–57). New York: The Guilford Press.
Wellisch, D. K., Centeno, J., Guzman, J., Belin, T. & Schiller, G. J. (1996). Bone marrow transplantation vs. high-dose cytorabine based consolidation chemotherapy for acute myelogenous leukemia. A long-term follow-up study of quality of life measures of survivors. Psychosomatics, 37(2), 144–54.Google Scholar
Zittoun, R., Achard, S. & Ruszniewski, M. (1999). Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. Psycho-oncology, 8(1), 64–73.3.0.CO;2-R>CrossRefGoogle Scholar
Zittoun, R., Suciu, S., Watson, M.et al. (1997). Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (Allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant, 20(4), 307–15.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×